Bryan K Yamamoto Selected Research

Bryan K Yamamoto Research Topics

Disease

9	Hyperthermia 10/2013 - 01/2003
6	Parkinson Disease (Parkinson's Disease) 01/2021 - 04/2013
6	Inflammation (Inflammations) 01/2021 - 01/2005
4	Mitochondrial Diseases (Mitochondrial Disease) 12/2008 - 01/2005
3	Substance-Related Disorders (Drug Abuse) 11/2018 - 04/2007
3	Seizures (Absence Seizure) 12/2016 - 05/2007
2	Alcoholism (Alcohol Abuse) 01/2021 - 01/2018
2	Cognitive Dysfunction 01/2017 - 10/2009
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2014 - 09/2003
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Brain Injuries (Brain Injury) 01/2018
1	Weight Gain 01/2016
1	Movement Disorders (Movement Disorder) 03/2015
1	Edema (Dropsy) 12/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2011
1	HIV Infections (HIV Infection) 02/2010
1	Neuroinflammatory Diseases 02/2010
1	Amphetamine-Related Disorders (Addiction, Amphetamine) 02/2010
1	Cocaine-Related Disorders (Cocaine Addiction) 09/2008
1	Hyperkinesis 05/2007
1	Psychotic Disorders (Schizoaffective Disorder) 05/2007
1	Catalepsy 05/2004
1	Necrosis 07/2003

Drug/Important Bio-Agent (IBA)

10	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021 - 04/2007
10	Dopamine (Intropin)FDA LinkGeneric 11/2018 - 01/2005
10	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 12/2016 - 01/2003
9	Serotonin (5 Hydroxytryptamine)IBA 01/2018 - 01/2003
4	cupric sulfide (CuS)IBA 01/2017 - 10/2009
4	Glutamic Acid (Glutamate)FDA Link 12/2016 - 01/2005
4	Levodopa (L Dopa)FDA LinkGeneric 09/2015 - 04/2013
3	CorticosteroneIBA 01/2016 - 05/2010
2	Kainic Acid (Kainate)IBA 12/2016 - 03/2016
2	Ketoprofen (Orudis)FDA LinkGeneric 09/2013 - 12/2012
2	AmphetaminesIBA 02/2010 - 05/2006
2	Amphetamine (Amfetamine)FDA LinkGeneric 12/2008 - 07/2003
2	Haloperidol (Haldol)FDA LinkGeneric 05/2007 - 05/2004
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	SynucleinsIBA 01/2021
1	Methadone (Dolophine)FDA LinkGeneric 01/2021
1	neurabinIBA 11/2018
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2018
1	LipopolysaccharidesIBA 01/2018
1	N-Methylaspartate (NMDA)IBA 12/2016
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2016
1	Dizocilpine Maleate (Dizocilpine)IBA 12/2016
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 12/2016
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 12/2016
1	SC 51089IBA 03/2016
1	AmmoniaIBA 01/2016
1	SaccharinIBA 01/2016
1	SolutionsIBA 01/2016
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2012
1	Dystroglycans (Dystroglycan)IBA 12/2012
1	Nerve Growth Factors (Neurotrophins)IBA 02/2010
1	UbiquitinIBA 02/2010
1	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2010
1	Cocaine (Cocaine HCl)IBA 09/2008
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 08/2007
1	Dopamine D2 Receptor AntagonistsIBA 05/2007
1	Antipsychotic Agents (Antipsychotics)IBA 05/2007
1	5-HT1B Serotonin ReceptorIBA 04/2007
1	Lobeline (Smokeless)IBA 01/2005
1	Clozapine (Clozaril)FDA LinkGeneric 05/2004
1	Serotonin ReceptorsIBA 09/2003
1	CalciumIBA 01/2003
1	Free RadicalsIBA 01/2003

Therapy/Procedure

2	Induced Hyperthermia (Thermotherapy) 09/2013 - 08/2009